Basma Mohamed Shehata
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Basma Mohamed Shehata has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Ahmed Ashraf Okba
Ain Shams University
1 shared publication Ahmed El-Nahrawy
Alexandria University, Alexandria, Egypt
1 shared publicationEman Mohamed Elsayed
Ain Shams University
1 shared publication- Hebatallah Ali Shaaban
Pediatric Department, Faculty of Medicine, Ain Shams University , Cairo, P.O. Box 11381
1 shared publication Maha Hassan Mohamed
Ain Shams University
1 shared publicationMohamed Mahmoud Khalifa
Ain Shams University
1 shared publication
Latest Publications
- 5 November 2026
- Published by SAGE Publications in Journal of Neonatal-Perinatal Medicine
Hemodynamic changes during total-body cooling and rewarming phase in neonates with hypoxic-ischemic encephalopathy
Introduction: Neonatal hypoxic-ischemic encephalopathy (HIE) is a major cause of neonatal morbidity and mortality. Therapeutic hypothermia (TH) is the standard neuroprotective intervention; however, it significantly influences cardiovascular function, necessitating careful hemodynamic monitoring. Aim: To evaluate hemodynamic changes in term neonates with HIE during therapeutic hypothermia and the subsequent rewarming phase using serial echocardiographic assessment. Materials and methods: This prospective observational study included 32 term neonates with suspected perinatal or intrapartum hypoxia admitted within 6 hours of birth. All patients underwent whole-body TH followed by controlled rewarming. Hemodynamic evaluation was performed using serial echocardiography at predefined time points during cooling and after rewarming. Cardiac troponin I levels were measured at admission, during cooling, and after rewarming, and compared with levels in healthy neonates. Results: Serial echocardiography demonstrated significant changes in cardiovascular function across the cooling and rewarming phases. Cardiac output, left ventricular output, fractional shortening, right ventricular output, and tricuspid annular plane systolic excursion showed significant changes over time, with several measures of ventricular systolic function improving after rewarming. Myocardial performance indices also decreased over time, indicating changes in global ventricular performance. Superior vena cava flow and pulmonary artery pressure increased during cooling and remained elevated during the early post-rewarming period. Inferior vena cava collapsibility and right ventricular systolic/diastolic indices also showed significant changes across the study period. Cardiac troponin I levels did not differ significantly between the cooling and post-rewarming measurements (0.19 ± 0.02 vs. 0.20 ± 0.02 ng/mL, P = 0.825). Correlations between echocardiographic parameters and clinical severity markers, including pH, Apgar score, and Sarnat stage, were variable. Conclusion: TH induces significant but reversible alterations in cardiac function in neonates with HIE. Serial echocardiographic assessment provides valuable insights into these dynamic changes and may support individualized cardiovascular management during both cooling and rewarming phases. Larger multicenter studies with longer follow-up are needed to determine their clinical significance and relationship with neonatal outcomes.
- 5 November 2026
- Published by SAGE Publications in Journal of Neonatal-Perinatal Medicine
Hemodynamic changes during total-body cooling and rewarming phase in neonates with hypoxic-ischemic encephalopathy
Introduction: Neonatal hypoxic-ischemic encephalopathy (HIE) is a major cause of neonatal morbidity and mortality. Therapeutic hypothermia (TH) is the standard neuroprotective intervention; however, it significantly influences cardiovascular function, necessitating careful hemodynamic monitoring. Aim: To evaluate hemodynamic changes in term neonates with HIE during therapeutic hypothermia and the subsequent rewarming phase using serial echocardiographic assessment. Materials and methods: This prospective observational study included 32 term neonates with suspected perinatal or intrapartum hypoxia admitted within 6 hours of birth. All patients underwent whole-body TH followed by controlled rewarming. Hemodynamic evaluation was performed using serial echocardiography at predefined time points during cooling and after rewarming. Cardiac troponin I levels were measured at admission, during cooling, and after rewarming, and compared with levels in healthy neonates. Results: Serial echocardiography demonstrated significant changes in cardiovascular function across the cooling and rewarming phases. Cardiac output, left ventricular output, fractional shortening, right ventricular output, and tricuspid annular plane systolic excursion showed significant changes over time, with several measures of ventricular systolic function improving after rewarming. Myocardial performance indices also decreased over time, indicating changes in global ventricular performance. Superior vena cava flow and pulmonary artery pressure increased during cooling and remained elevated during the early post-rewarming period. Inferior vena cava collapsibility and right ventricular systolic/diastolic indices also showed significant changes across the study period. Cardiac troponin I levels did not differ significantly between the cooling and post-rewarming measurements (0.19 ± 0.02 vs. 0.20 ± 0.02 ng/mL, P = 0.825). Correlations between echocardiographic parameters and clinical severity markers, including pH, Apgar score, and Sarnat stage, were variable. Conclusion: TH induces significant but reversible alterations in cardiac function in neonates with HIE. Serial echocardiographic assessment provides valuable insights into these dynamic changes and may support individualized cardiovascular management during both cooling and rewarming phases. Larger multicenter studies with longer follow-up are needed to determine their clinical significance and relationship with neonatal outcomes.
- 5 August 2025
- Published by SAGE Publications in Journal of Neonatal-Perinatal Medicine
- Vol. 19 (1) , 69-77
Thoracic fluid content by electric cardiometry versus lung ultrasound in preterm neonates with respiratory distress: A prospective study
Background: Respiratory distress (RD) is a major cause of admission to neonatal intensive care units (NICUs), highlighting the need for prompt and accurate assessment. Lung ultrasound (LUS) has emerged as a rapid, non-invasive, radiation-free tool with superior sensitivity to chest X-ray. Thoracic Fluid Content (TFC), measured via electrical cardiometry, may serve as a complementary parameter by reflecting pulmonary fluid load. Consequently, this study aimed to evaluate the predictive accuracy of TFC and LUS in determining the need for surfactant therapy or initiation of positive pressure ventilation in preterm neonates with respiratory distress. Patients and Methods: In this prospective observational cohort study, 70 preterm neonates with RD were enrolled between April 2022 and April 2024 in the NICU of Ain Shams University, Cairo, Egypt. LUS and TFC were measured on day 1 and day 3 of life. Clinical outcomes, including surfactant need and escalation of ventilation, were recorded. Results: An LUS score >5 strongly predicted surfactant need, showing 88.89% sensitivity and 86.05% specificity (AUC: 0.941; PPV: 80%; NPV: 92.5%). TFC values were higher in neonates who received surfactant, though not statistically significant ( p = 0.053). A significant positive correlation was observed between TFC and LUS scores (r = 0.311, p = 0.009). Conclusion: LUS is a reliable predictor of surfactant need and respiratory support in preterm neonates with RD. While TFC correlates with LUS in assessing pulmonary fluid status, it alone did not independently predict clinical intervention requirements.
- 5 August 2025
- Published by SAGE Publications in Journal of Neonatal-Perinatal Medicine
- Vol. 19 (1) , 69-77
Thoracic fluid content by electric cardiometry versus lung ultrasound in preterm neonates with respiratory distress: A prospective study
Background: Respiratory distress (RD) is a major cause of admission to neonatal intensive care units (NICUs), highlighting the need for prompt and accurate assessment. Lung ultrasound (LUS) has emerged as a rapid, non-invasive, radiation-free tool with superior sensitivity to chest X-ray. Thoracic Fluid Content (TFC), measured via electrical cardiometry, may serve as a complementary parameter by reflecting pulmonary fluid load. Consequently, this study aimed to evaluate the predictive accuracy of TFC and LUS in determining the need for surfactant therapy or initiation of positive pressure ventilation in preterm neonates with respiratory distress. Patients and Methods: In this prospective observational cohort study, 70 preterm neonates with RD were enrolled between April 2022 and April 2024 in the NICU of Ain Shams University, Cairo, Egypt. LUS and TFC were measured on day 1 and day 3 of life. Clinical outcomes, including surfactant need and escalation of ventilation, were recorded. Results: An LUS score >5 strongly predicted surfactant need, showing 88.89% sensitivity and 86.05% specificity (AUC: 0.941; PPV: 80%; NPV: 92.5%). TFC values were higher in neonates who received surfactant, though not statistically significant ( p = 0.053). A significant positive correlation was observed between TFC and LUS scores (r = 0.311, p = 0.009). Conclusion: LUS is a reliable predictor of surfactant need and respiratory support in preterm neonates with RD. While TFC correlates with LUS in assessing pulmonary fluid status, it alone did not independently predict clinical intervention requirements.